Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Foley

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Journal of Medicinal Chemistry|May 5, 2021
Macrocyclic Peptides that Selectively Inhibit the <i>Mycobacterium tuberculosis</i> ProteasomeHao Zhang, Hao-Chi Hsu, Shoshanna C Kahne, et al.
Cell|September 12, 2015
Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs SurvivalAmelia J Johnston, Kate T Murphy, Laura Jenkinson, et al.
European Heart Journal. Digital Health|August 4, 2023
Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessmentHenry Seligman, Sapna B Patel, Anissa Alloula, et al.
ACS Medicinal Chemistry Letters|February 14, 2012
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of MalariaRichard W Heidebrecht, Carol Mulrooney, Christopher P Austin, et al.
Circulation. Cardiovascular Interventions|August 3, 2021
Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery DiseaseChristopher A Rajkumar, Matthew Shun-Shin, Henry Seligman, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry PerspectiveHugo M Vargas, Michael G Rolf, Todd A Wisialowski, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 23, 2023
The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visuallyMichael Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Journal of Medicinal Chemistry|May 5, 2021
Macrocyclic Peptides that Selectively Inhibit the <i>Mycobacterium tuberculosis</i> ProteasomeHao Zhang, Hao-Chi Hsu, Shoshanna C Kahne, et al.
Cell|September 12, 2015
Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs SurvivalAmelia J Johnston, Kate T Murphy, Laura Jenkinson, et al.
European Heart Journal. Digital Health|August 4, 2023
Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessmentHenry Seligman, Sapna B Patel, Anissa Alloula, et al.
ACS Medicinal Chemistry Letters|February 14, 2012
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of MalariaRichard W Heidebrecht, Carol Mulrooney, Christopher P Austin, et al.
Circulation. Cardiovascular Interventions|August 3, 2021
Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery DiseaseChristopher A Rajkumar, Matthew Shun-Shin, Henry Seligman, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry PerspectiveHugo M Vargas, Michael G Rolf, Todd A Wisialowski, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 23, 2023
The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visuallyMichael Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Pageof 17